Healthcare provider profile · identity verified

Daniel Alexander Placik, MD

Family Practice · SAN PEDRO, CA · NPI 1932690484

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	945	245
Amlodipine Besylate	Amlodipine Besylate	620	162
Metformin Hcl	Metformin Hcl	464	119
Omeprazole	Omeprazole	360	98
Losartan Potassium	Losartan Potassium	350	113
Lisinopril	Lisinopril	276	84
Gabapentin	Gabapentin	214	70
Levothyroxine Sodium	Levothyroxine Sodium	193	57
Rosuvastatin Calcium	Rosuvastatin Calcium	192	54
Tamsulosin Hcl	Tamsulosin Hcl	191	63
Pioglitazone Hcl	Pioglitazone Hcl	166	49
Simvastatin	Simvastatin	165	35
Metoprolol Succinate	Metoprolol Succinate	160	44
Pantoprazole Sodium	Pantoprazole Sodium	146	35
Fluticasone Propionate	Fluticasone Propionate	136	57
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	132	43
Furosemide	Furosemide	131	40
Escitalopram Oxalate	Escitalopram Oxalate	129	44
Hydrochlorothiazide	Hydrochlorothiazide	122	43
Famotidine	Famotidine	96	30
Albuterol Sulfate Hfa	Albuterol Sulfate	83	34
Alendronate Sodium	Alendronate Sodium	82	26
Glimepiride	Glimepiride	79	24
Tramadol Hcl	Tramadol Hcl	79	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	26
Metoprolol Tartrate	Metoprolol Tartrate	78	19
Clopidogrel	Clopidogrel Bisulfate	76	22
Ozempic	Semaglutide	74	21
Carvedilol	Carvedilol	72	24
Finasteride	Finasteride	71	20
Montelukast Sodium	Montelukast Sodium	70	13
Clonidine Hcl	Clonidine Hcl	69	14
Olanzapine	Olanzapine	68	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	67	suppressed
Trazodone Hcl	Trazodone Hcl	66	24
Glipizide	Glipizide	65	21
Pravastatin Sodium	Pravastatin Sodium	65	19
Januvia	Sitagliptin Phosphate	63	16
Alprazolam	Alprazolam	60	15
Lorazepam	Lorazepam	60	22
Eliquis	Apixaban	59	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	20
Xarelto	Rivaroxaban	52	13
Diclofenac Sodium	Diclofenac Sodium	49	18
Donepezil Hcl	Donepezil Hcl	49	11
Azithromycin	Azithromycin	48	43
Aripiprazole	Aripiprazole	46	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	42
Allopurinol	Allopurinol	44	13
Temazepam	Temazepam	44	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	13
Benazepril Hcl	Benazepril Hcl	42	15
Duloxetine Hcl	Duloxetine Hcl	41	19
Triamcinolone Acetonide	Triamcinolone Acetonide	41	26
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	12
Meclizine Hcl	Meclizine Hcl	37	13
Zolpidem Tartrate	Zolpidem Tartrate	37	14
Farxiga	Dapagliflozin Propanediol	36	12
Atenolol	Atenolol	35	12
Metformin Hcl Er	Metformin Hcl	33	12
Mirtazapine	Mirtazapine	33	12
Ketoconazole	Ketoconazole	31	12
Cephalexin	Cephalexin	28	24
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Jardiance	Empagliflozin	25	13
Naproxen	Naproxen	25	13
Valsartan	Valsartan	25	suppressed
Risperidone	Risperidone	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Felodipine Er	Felodipine	23	suppressed
Meloxicam	Meloxicam	23	14
Sertraline Hcl	Sertraline Hcl	23	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Clonazepam	Clonazepam	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Azelastine Hcl	Azelastine Hcl	20	13
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	17	suppressed
Testosterone	Testosterone	17	suppressed
Xifaxan	Rifaximin	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Topiramate	Topiramate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Baclofen	Baclofen	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Prednisone	Prednisone	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Nystatin	Nystatin	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error